Chris Moore

Big data is the phenomenon of our time. The combination of the astonishing explosion of data and the rapid development of new technologies capable of storing and processing this information will transform the way enterprises run their businesses. After an initial period, when big data was an optional extra for most businesses, its value is now widely accepted. Big data and analytics are starting to enter the mainstream of daily business practice.

The time has come to verify that business decisions predicated on the conclusions of profoundly complex science are not putting excessive shareholder value at risk. Yearly, almost US$200 billion are spent on research and development (R&D) in science-driven sectors such as healthcare, life sciences, consumer products or chemicals.Sixty percent of pharmaceutical R&D investments is spent on products that will never reach the market. The past decade has seen a rising number of public health and… Show more

The time has come to verify that business decisions predicated on the conclusions of profoundly complex science are not putting excessive shareholder value at risk. Yearly, almost US$200 billion are spent on research and development (R&D) in science-driven sectors such as healthcare, life sciences, consumer products or chemicals.Sixty percent of pharmaceutical R&D investments is spent on products that will never reach the market. The past decade has seen a rising number of public health and environmental issues following incorrect scientific claims and a ten-fold increase in scientific paper retractions. We believe that an independent, systematic and unbiased process for auditing scientific claims can help increase companies’ confidence in scientific outcomes, reduce risks, pilot innovation and generate more value for consumers, the environment and businesses. Show less